In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioPort Corp.

Latest From BioPort Corp.

Recent Dealmaking (3/2003)

Summarizing the month in European dealmaking.

The Dawning of the Life Sciences Defense Industry

To former SmithKline Beecham R&D head George Poste, the engagement of government and industry to combat biothreats is not a matter of choice or even enlightened self-interest, but an imperative. For the past five years, he has been participating in the activities of the US Defense Science Board and engaging industry on the subject of bioterrorism and the broader issue of the spread of infectious disease. In an extensive interview with IN VIVO, he argues for creation of a life sciences defense industry--a closer and deeper relationship between government and the private sector that will mean a loss of innocence for the historically open life sciences culture. And he says government must address the lack of adequate incentives, which has discouraged private-sector participation in the past.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • BioPort Corp.
  • Senior Management
  • Fuad El-Hibri, Chmn. & CEO
    Michael Zamiara, CFO & VP, Fin. & Admin.
    Robert G Kramer, Sr., Pres., COO, & Dir.
  • Contact Info
  • BioPort Corp.
    Phone: (517) 327-5540
    3500 N. Martin Luther King Jr. Blvd.
    Lansing, MI 48906